We propose a revised standardized nomenclature for the proteins common to all retroviruses on the basis of biological function, enzymatic activity, and/or virion location data. (We do not discuss proteins specific for subfamilies or only some retroviruses.)
During the past decade, the retrovirus proteins have been designated by the letter "p" followed by an approximate molecular weight estimated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis or gel filtration data (1) . original molecular weight estimates for some of the proteins were inaccurate.
We propose a unified nomenclature for retrovirus proteins on the basis of known biological function, location in virions, (7) . An example of the use of the new acronyms follows. The avian sarcoma and leukosis virus (ASLV) p15 protease would be referred to as the ASLV PR, or the murine leukemia virus (MuLV) plO nucleocapsid protein would be referred to as the MuLV NC. In cases in which it is important to indicate the gene origin of a protein, the use of a superscript is recommended (e.g., PR9'9).
An acronym has not been chosen for the ASLV plO, MuLV p12, mouse mammary tumor virus p21, or MasonPfizer monkey virus p18 because information about their virion locations or functions is lacking. It is recommended that the old nomenclature be used in these cases.
We believe that this system is appropriate to use at this time because it is based on our increased understanding of viral functions. Additional advantages are (i) it is simple, (ii) it avoids confusion in describing the proteins of similar function in different virus species, and (iii) it is similar to nomenclature used for other animal viruses.
